Dr. Liewen studied Medicine in Mainz and Frankfurt. After a clinical education in Neurology she started a cancer research fellowship at the
Burnham Institute, La Jolla (USA) at Dr. John C. Reed's laboratory. From there she moved on to research at the University Hospital Homburg/ Saar (D) and the University Hospital Zurich
(CH). She founded and heads Cureab since 2012.
Dr. Heike Liewen CEO
Publications in ORCID
note: required fields *
we strive to provide patients with novel next generation antibodies for better
cancer therapies in tumours with a high medical need. Colorectal Cancer will be the beginning.